Two new vaccines may prevent recurrence in ovarian and breast cancer
Aug 19, 2011
It was recently announced that the Mayo Clinic believes they have found two vaccines that can fight against cancer recurrence. The team of researchers got the approval from the FDA to start testing them on women who have been treated for ovarian or breast cancer, according to the Toronto Sun.
"I'm quite optimistic that if we can combine early detection, effective conventional therapies and vaccination, we can reduce recurrence and long-term morbidity associated with breast and ovarian cancer," immunologist Keith Knutson told the news source.
Knutson added that he thinks this a very real possibly - vaccinating against cancer. Their goal is to vaccinate individuals right after they beat the cancer the first time, and they are still healthy, the media outlet reports.
According to the Susan G. Komen organization, one in eight women in the U.S. will eventually be diagnosed with breast cancer at some point during their lifetime. This disease is the second leading cancer-related cause of death among women, second only to lung cancer.